Hoarding: Clinical Trials

3 trials for Hoarding, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3
Phase 11Completed 1

Follow Hoarding: new trials by email Literature Review of Hoarding trials Research Report on Hoarding

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Epidiolex in Obsessive Compulsive Disorder and Related Disorders
Cannabidiol - Obsessive-Compulsive Disorder, Trichotillomania (Hair-Pulling Disorder)
Phase 2CompletedUniversity of Chicago42022-04-142026-07-29
Enhancing Attention in Adults With Compulsive Hoarding
Methylphenidate ER - Hoarding Disorder
Phase 2CompletedNew York State Psychiatric Institute42010-04-012014-09-18
Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project
Cognitive-behavioral therapy, Wait-list control - Prader Willi Syndrome, Obsessive-compulsive Disorder
Phase 1 / Phase 2CompletedUniversity of South Florida242008-09-012011-08-08

Narrower conditions

Hoarding Disorder (2)  ·  Obsessive-Compulsive Disorder (2)  ·  Compulsive Behavior (1)  ·  Disease (1)  ·  Excoriation Disorder (1)  ·  Prader-Willi Syndrome (1)  ·  Tourette Syndrome (1)  ·  Trichotillomania (1)

Broader conditions

Anxiety Disorders (3)  ·  Behavior (3)  ·  Mental Disorders (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Genetic Diseases, Inborn (2)  ·  Nervous System Diseases (2)  ·  Abnormalities, Multiple (1)  ·  Basal Ganglia Diseases (1)  ·  Behavioral Symptoms (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Chromosome Disorders (1)  ·  Congenital Abnormalities (1)  ·  Disruptive, Impulse Control, and Conduct Disorders (1)  ·  Heredodegenerative Disorders, Nervous System (1)

Interventions

Cannabidiol (1)  ·  Cognitive Behavioral Therapy (1)  ·  Methylphenidate (1)

Sponsors

New York State Psychiatric Institute (1)  ·  University of Chicago (1)  ·  University of South Florida (1)

Countries

United States (3)

Top investigators

Carolyn I. Rodriguez, M.D., Ph.D. (1)  ·  Eric Storch, Ph.D. (1)  ·  Jon E Grant, MD, JD, MPH (1)